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Abstract 
Background: Malaria is a major public health problem and still reported among the 10 top causes of morbidity and 
mortality in Ethiopia. More than one-third of the people sought treatment from the private health sector. Evaluat-
ing adherences of health care providers to standards are paramount importance to determine the quality and the 
effectiveness of service delivery. Therefore, the aim of this study was to evaluate the contribution of public private mix 
(PPM) approach in improving quality of malaria case management among formal private providers.
Methods: A retrospective data analysis was conducted using 2959 facility-months data collected from 110 PPM for 
malaria care facilities located in Amhara, Dire Dawa, Hareri, Oromia, Southern Nation Nationalities and Peoples and 
Tigray regions. Data abstraction formats were used to collect and collate the data on quarterly bases. The data were 
manually cleaned and analysed using Microsoft Office Excel 2010. To claim statistical significance non-parametric 
McNemar test was done and decision accepted at P < 0.05.
Results: From April 2012–September 2015, a total of 873,707 malaria suspected patients were identified, of which 
one-fourth (25.6 %) were treated as malaria cases. Among malaria suspected cases the proportion of malaria inves-
tigation improved from recorded in first quarter 87.7–100.0 % in last quarter (X2 = 66.84, P < 0.001). The majority 
(96.0 %) were parasitologically-confirmed cases either by using microscopy or rapid diagnostic tests. The overall slid 
positivity rate was 25.1 % of which half (50.7 %) were positive for Plasmodium falciparum and slightly lower than half 
(45.2 %) for Plasmodium vivax; the remaining 8790 (4.1 %) showed mixed infections of P. falciparum and P. vivax. Adher-
ence to appropriate treatment using artemether-lumefantrine (AL) was improved from 47.8 % in the first quarter to 
95.7 % in the last quarter (X2 = 12.89, P < 0.001). Similarly, proper patient management using chloroquine (CQ) was 
improved from 44.1 % in the first quarter to 98.12 % in the last quarter (X2 = 11.62, P < 0.001).
Conclusions: This study documented the chronological changes of adherence of health care providers with the 
national recommended standards to treat malaria. The PPM for malaria care services significantly improved the 
malaria case management practice of health care providers at the formal private health facilities. Therefore, regional 
health bureaus and partners shall closely work to scale up the initiated PPM for malaria care service.
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Background
Malaria is caused by the protozoan parasite of the genus 
Plasmodium and transmitted by Anopheles mosqui-
toes. Globally, it is an important public health problem. 
According to the World Health Organization (WHO) 
global malaria report 2015, there were an estimated 
214 million in 2015 (range 194–303 million) cases. Most 
of the estimated cases (88 %) occurred in WHO African 
Region. In the same year, an estimated 438,000 deaths 
were reported, mostly (90 %) in the African Region [1].
In Ethiopia, malaria is a major public health problem. 
Approximately over 50 million (60 %) of the population 
live in malaria endemic area, mainly at altitudes below 
2000 m above sea level [2]. According to Ethiopian Fed-
eral Ministry of Health (EFMOH 2013/2014), there were 
57,503 public sector malaria hospitalizations, 4.9 million 
malaria outpatient cases, and the majority 2.9  million 
were laboratory-confirmed Plasmodium falciparum out-
patient malaria cases, and 1.2 million were Plasmodium 
vivax cases [3].
Malaria is a significant impediment to social and eco-
nomic development in Ethiopia. In endemic areas, 
malaria has affected the population during planting and 
harvesting seasons, cutting down productive capacity at a 
time when there is the greatest need for agricultural work. 
The disease has also been associated with loss of earnings, 
low school attendance, and high treatment cost [3–5].
In the last 5  decades, Ethiopia has executed all three 
WHO recommended malaria prevention and control 
strategies i.e. early diagnosis and prompt treatment, vec-
tor control and epidemic prevention and control [4, 6]. 
Currently, malaria care services in public health facilities 
are offered free of charge at all three levels of the health 
care tier system. Despite the effort made by the govern-
ment to improve access and quality of services in public 
health facilities, significant numbers of the community 
members sought treatment from the private health sector 
[7–9].
On one hand, evidences from countries with different 
modality working with private health sector on malaria 
case management revealed improved quality of services 
[10–14]. On the other hand, there are reported challenges 
facing the health system due to unregulated private sec-
tor through poor adherence to the nationally recom-
mended standards for malaria case management [15, 16]. 
In the context of malaria elimination, working with the 
private health sector is essential to ensure complete and 
timely reporting of all malaria cases and ensuring access 
to effective case management for people seeking treat-
ment from private providers [1]. WHO developed the 
Global technical strategy for malaria 2016–2030, which 
sets the most ambitious targets for reduction in malaria 
cases and deaths since the malaria eradication era began 
[17]. This strategy was developed in line with the roll 
back malaria (RBM) partnership’s Action and investment 
to defeat malaria, to ensure shard goals and complemen-
tarity. The strategy has three main building blocks. The 
first pillar is to ensure universal access to malaria pre-
vention, diagnosis and treatment. The second pillar is 
to accelerate efforts towards elimination of malaria and 
the third pillar is to transform malaria surveillance into a 
core intervention [17, 18].
In many developing countries the private health sec-
tor provides public health care and services for about one 
half of their population [1, 19, 20]. The situation in Ethio-
pia is quite similar with other SSA countries [19]. How-
ever, very few studies were documented on the role of 
private health facilities on malaria control and the quality 
of care in Ethiopia [21–23]. Jerne et al. state that out of 
102 survey facilities in Oromia Regional State of Ethiopia, 
86.0  % were providing malaria diagnosis and treatment 
services [21]. They also stated that the private health sec-
tor were not part of malaria case management training 
and didn’t get opportunity to be familiar with the most 
resent recommendations [21, 22]. Moreover, there was no 
strong established system to ensure the efficacy of drug 
accessed through private sector [17]. On top of these, the 
cost of full dose of artemether-lumefantrine (Coartem®) 
available through the private sector was found to be high 
and challenges the affordability of services to the general 
population.
Public Private Partnership (PPP) for malaria care ser-
vice in Ethiopia has been implemented by six Regional 
State Health Bureaus and United State Agency for Inter-
national Development (USAID) Funded Private Health 
Sector Programme (PHSP) (2009–2015). PHSP provided 
technical support for Regional Health Bureaus to take the 
leadership and stewardship on PPP and private facilities 
to be committed for the success of the national vision 
‘seeing malaria free Ethiopia’. One hundred ten private 
health facilities engaged in the implementation of the 
malaria care services through initiated partnerships [19, 
24, 25].
This retrospective study was conducted to analyse 
forty-two months’ health facility quarterly reports on 
malaria service delivery to assesses magnitude of cases 
and adherence of health care workers on the national 
standards. The result of this study will be useful for 
policy-makers, programme managers and health care 




Ethiopia is located in the horn of Africa with an area 
of estimated 1.1  million sq. km [26]. This data analysis 
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covers five regional state and one city administration 
where over 54.5 million people live at risk of malaria [3].
Process of establishing PPP for malaria care
Private Health Sector Programme (PHSP) was a 6 years 
project (September 2009–September 2015), funded 
by United States Agency for International Develop-
ment (USAID). PHSP was the successor of Private Sec-
tor Project (PSP), which has piloted Public Private Mix 
Directly Observed Therapy Short Course (PPM_DOTS) 
and Human Immuno-deficiency Virus (HIV) programs 
in Ethiopia and concluded with recommendation to scale 
up the approach to maximize the health impact of the 
partnership [19, 24, 25].
PHSP provided its technical support in the implemen-
tation of PPM for human immuno-deficiency virus (HIV) 
acquired immune deficiency syndrome (AIDS), tubercu-
losis (TB), malaria, family planning (FP), sexually trans-
mitted infections (STI) programmes for five regional 
states and two city administrations namely: Amhara, 
Oromia, Tigray, Southern Nations Nationalities and Peo-
ples (SNNP), Hareri Regions and Dire Dawa and Addis 
Ababa City Administration. Moreover, PHSP built the 
capacity of 342 private health facilities, primarily private 
for profit, followed by private not for the profit (faith 
based organization) and the third group were work place 
facilities; with the goal of establishing effective public 
private partnership for improving access to and demand 
for quality public health services with affordable costs. 
The malaria programme was implemented in 110 private 
health facilities (Fig. 1) [24].
Foundation
PHSP has implemented its project using its programme 
implementation strategies [24] with step ladder fashion 
(Fig. 2). The first phase of the implementation strategy is 
dedicated to construct the foundation of PPP approaches. 
PHSP has conducted preliminary discussions with all 
Regional State Health Bureaus (RHBs). Then, consensus 
building workshops were held with delegates of public 
sector, private sector and other relevant stakeholders. 
PHSP in collaboration with RSHBs conducted facility 
readiness assessment from January through September 
2012. Using a predetermined objective criteria like ser-
vice integration, malaria case load, human resources, 
willingness and commitment of private health facilities 
owners, 110 health facilities i.e. seven Primary (Lower 
Clinics), 10 Hospitals, 37 Higher Clinics and 56 Medium 
Clinics were selected [24]. Moreover, Referral directory 
were developed and distributed to all actors for smooth 
Fig. 1 Map of location of Ethiopia in Africa and distribution of PPP for malaria care facilities. Map of study area with distribution of Public Private 
partnership for malaria care health facilities in Ethiopia
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networking. Therefore, this was the time which builds the 
capacity of public sector leadership and governance in 
owning the partnerships at regional health bureaus and 
its line structures.
Capacity building
Before commencing the PPP for malaria care services, 
PHSP provided a team based trainings for case, labora-
tory and supply chain managers. The staff underwent 
4 days of malaria case management and malaria diagnosis 
methods trainings. The third person attended nationally 
recommended 3  day training on supply chain manage-
ment using standard operating procedure (SOP) for inte-
grated pharmaceutical logistics system (IPLS).
In the implementation strategy after working on foun-
dation, capacity building would resume in the parameter 
of clinical and non-clinical areas which include: training 
for private health facility owners on business manage-
ment, signing of memorandum of understandings, link-
ing facilities to public health supplies system and site 
preparation. During the study periods 344 malaria case 
managers were trained in twelve sessions. One hundred 
eighty five laboratory personnel were trained on malaria 
diagnosis, internal quality control (IQC), and external 
quality assurance (EQA) furthermore 140 supply chain 
mangers were trained in five sessions.
Service delivery
The third and final steps are service delivery which 
includes service initiation, advocacy, demand creation 
supervision and mentoring. On a quarterly basis, tech-
nical assistances for all facilities was provided by a team 
of malaria expert from Woreda health office, laboratory 
quality officer, pharmacy mentor and programme offic-
ers. In addition, demands were created using 347 spot 
health radio messages in five local languages i.e. Amharic, 
Hareri, Oromiffa, Somali and Tigrigna, distribution of 
168,500 patient brochures and 29,000 posters [24].
Quality assurance
PHSP adopt, print and distribute a set of malaria morbid-
ity and mortality register, comprehensive laboratory reg-
ister, weekly reporting forms, national malaria guidelines 
and job aids. Furthermore, joint supportive supervisions 
were conducted on quarterly bases by a team of malaria 
experts from public sector, clinical officer, laboratory 
quality officer and pharmacy mentor.
The established partnerships need commitment of pri-
vate health facilities to serve the community only with 
consultation and laboratory service fees. As per the signed 
Memorandum of Understanding (MOU) with or between 
RHB, confirmed P. falciparum cases should get AL (Coar-
tem) for free of charge while P. vivax cases should be 
Fig. 2 Private health sector programme implementation strategies. Figure depicting the step ladder fashion implementation strategies followed by 
the project which includes foundation, capacity building, service delivery, exit and continuous quality improvement cycles
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treated with chloroquine. In addition, the health facili-
ties are expected to document the result of IQC and EQA 
results. Finally, the overall implementation of malaria case 
detection and management is verified through continuous 
quality improvement approaches [24].
Data collection methods and data quality
This retrospective descriptive study [27] was conducted 
to determine malaria prevalence and adherence of 
health care providers to national standards using forty-
two months or 2959 facility-months data i.e. from April 
2012–September 2015. The data were collected from 110 
Public Private Partnership (PPP) for malaria care facilities 
located in six regional states of Ethiopia. Data were col-
lected using the pretested data abstraction form through 
reviewing primary source from comprehensive labora-
tory and malaria morbidity registers which consists of 
age, sex, date seen at health facility, diagnosis, treatment, 
history of admission, referral and outcome of admitted 
malaria patients. The tool has facility identifiers, data col-
lection period and detail malaria case information.
In all PHSP supported private health facilities, malaria 
was diagnosed using standard operating procedure either 
using Giemsa (3 or 10 %) stained blood film or multi spe-
cies malaria rapid diagnostic test kits (RDT). Only pri-
mary clinics (lower clinics) were expected to use RDTs to 
diagnose malaria. The data were collected by nine team 
composed of trained twenty four public health profes-
sionals (regional programme coordinators and program 
officers) and the data quality were ensured through reg-
ularly conducted data quality assessment by continuous 
quality improvement experts. The teams found margins 
of errors of less than 3 % [20].
Data analysis
The summaries of quarterly reports were transferred 
to continuous quality improvement team through 
Open Data Kit (ODK) using smart phones. For statisti-
cal analysis the data were exported to Microsoft Excel 
2010. The data were cleaned and checked for consisten-
cies. Descriptive statistical analysis [27] (Frequency dis-
tribution and line graphs for trend analysis) were made. 
Botma et  al. [28] recommended a non-parametric sta-
tistical analysis, McNemar Chi square test for paired or 
dependent proportions. For this retrospective descriptive 
study, McNemar’s test is selected, where each nominal 
data in the first quarter was paired with the last quarter 
data. Statistically significant relationship was claimed at 
P < 0.05 [28].
Ethical clearance
The research protocol of this retrospective study was not 
reviewed by research ethics committee. As one of the 
project activity permission to use the data were sought 
and obtained from Private Health Sector Project, Abt 
Associated Inc. in Ethiopia. Patient identifier information 
was not collected. As per the requirement of the public 
health system summarized information’s were submitted 




A complete set of 2959 months-facility malaria morbidity 
data were collected on quarterly bases from 110 malaria 
care services facilities located in six regional states of 
Ethiopia. Between the initiation of PPP for malaria care 
services and September 2015, a total of 873,707 malaria 
suspected patients were identified, of which 223,293 
(25.6 %) were treated as malaria cases. Almost all 214,259 
(96.0  %) were parasitological confirmed either using 
microscopy or malaria RDTs. The rest 9034 (4.0 %) were 
diagnosed by clinical signs or symptoms as presumed 
malaria cases (Table 1).
The majority (63.7 %) of malaria suspected cases were 
served at medium clinics, followed by higher clinics 
(18.7 %). The third largest group of patients (13.8 %) was 
served in lower clinics and the rest of malaria suspected 
cases (3.8 %) were served in Hospitals.
The majority 133,876 (60.0 %) of malaria patients were 
males. However, this gender difference in utilization of 
the service among malaria patient increased when the 
age group increased from lower to next higher age cate-
gory. Two-third (68.9 %) were patients in the age category 
15  years old or more, followed by 15.8  % were children 
5–14  years old and the rest 15.2  % were under 5  years 
old children (Table  2). The majority 87.1  % of malaria 
suspected cases was serviced in private for profit facili-
ties, followed by 9.7 % of malaria suspected patients were 
served in workplace facilities (Fig. 3).
Malaria diagnosis
The malaria microscopy slide positivity rate was 24.5  % 
(198,066/807,275). Almost half of confirmed cases 
(50.4  %) were P. falciparum, 45.6  % were P. vivax (and 
the rest (4.1 %) were mixed species P. falciparum/P. vivax 
infections (Table 3). The malaria RDT positivity rate was 
36.2  %. The Plasmodium species identified using RDT: 
55.0 % were P. falciparum, 40.2 % were P. vivax, and 4.7 % 
were mixed infections (Table 4). The overall malaria para-
site detection rate (either using microscopy or RDT) was 
25.1 % (214,259/851,994). And the proportion of Plasmo-
dium species confirmed in PPP facilities consists of 50.7 % 
were P. falciparum, 45.2 % were P. vivax and 4.1 % were 
mixed infections (Table  3). Making malaria diagnosis 
according to the national standards with parasitological 
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confirmation was significantly improved from 87.7  % 
during the first 3  months to almost 100.0  % in the last 
3 months, and PPP for malaria care facilities showed up 
their commitment with sustaining the results (Fig. 4).
Malaria case management
In this study, at the time of initiation of PPP for malaria 
care service (April–June 2012) adherence of health 
workers to the standards of P. falciparum (AL) infec-
tion treatment was improved from 47.8 % (2501/5223) to 
95.7  % (3417/3567) in the last quarter (July–September 
2015) with wide range from 56.0 to 95.1 % achievements 
for the rest of the quarters (Fig. 5). Similarly, adherence 
to P. vivax treatment (CQ) was 44.1 % (1425/3225) in the 
first quarter and 98.1  % (3295/3358) in the last quarter 
with range 76.3–100.0  % of performance was recorded 
within the study period (Fig.  6), respectively. The tem-
poral changes of improvements in treatment adherence 
with the national recommended standards were evalu-
ated using with non- parametric statistics McNemar’s 
test. Computing the changes in improvement of malaria 
management of the first against the last quarter for AL 
and CQ was found statistically significant at P  <  0.001 
(Table 4).
Discussion
This study determined the magnitude of malaria among 
self-reported suspected cases in PPP for malaria care 
facilities from April 2012 through September 2015 in 
six regional states of Ethiopia. The study describes the 
prevalence of Plasmodium species, service beneficiar-
ies by age category, sex and years. In addition, the study 
documented the significant improvement in adherence 
of health care providers with national standards recom-
mended for diagnosis and treatment.
The majority 96.0  % of malaria patients treated 
in selected 110 PPP for malaria care facilities were 
Table 1 Malaria suspected, parasitological confirmed and clinically identified malaria cases in Ethiopia, April 2012–Sep-
tember 2015
a χ2 = 14.061, df = 3, χ2/df = 4.69, P (χ2 >14.061) = 0.0028




% Malaria cases (con-
firmed + clinical)a
% Confirmed malaria 
cases
% Clinical malaria 
cases
%
2012 (1) 71,800 62,455 87.0 26,817 37.3 24,698 92.1 2119 7.9
2013 (2) 292,986 288,225 98.4 89,985 30.7 84,080 93.4 5905 6.6
2014 (3) 336,250 328,760 97.8 74,566 22.2 73,673 98.8 893 1.2
2015 (4) 172,671 172,554 99.9 31,925 18.5 31,808 99.6 117 0.4
Grand total 873,707 851,994 97.5 223,293 25.6 214,259 96.0 9034 4.0
Table 2 Distribution of malaria by age, sex and pregnancy status in Ethiopia, April 2012–September 2015
Year 0–4 years 5–14 years 15 + years Males Females
M F M F M F Freq. % Freq. %
2012 (1) 2495 1813 2361 1862 10,490 7796 15,346 57.2 11,471 42.8
2013 (2) 8207 6282 8910 6434 35,987 24,165 53,104 59.0 36,881 41.0
2014 (3) 6145 4685 6260 4832 32,830 19,814 45,235 60.6 29,331 39.3
2015 (4) 2296 1708 2468 1918 15,427 8108 20,191 63.2 11,734 36.7
Grand total 19,143 14,488 19,999 15,046 94,734 59,883 133,876 60.0 89,417 40.0
Fig. 3 Pie chart depicted proportion of malaria care services 
beneficiaries by ownership of facilities, April 2012–September 2015 
(n = 223, 293)
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parasitological confirmed either using microscopy or 
RDT. This finding is a little higher than the national 
estimated 60.0 and 84.1  % confirmed malaria patient 
treated in private and public health facilities in Ethiopia, 
respectively [3, 22]. This successful achievement could 
be related to the effective intervention (technical sup-
port, joint supportive supervisions, team trainings, men-
torships and access to supplies) made by the RHBs and 
PHSP.
This study revealed that 60  % of malaria patients sur-
veyed in PPP for malaria facilities were males. But this 
difference significantly reduced when the age of patients 
falls in the lower age category. This finding is in line with 
Yukich et  al. [29] and Regassa [30] describe the pres-
ence of higher risk of malaria infection among adults and 
males in Ethiopia. On the other hand adult males might 
have better economic position and decision power in 
seeking medical care than females [5]. In Kenya, a result 
of large national survey documented females are 1.4 
times more likely acquire to malaria than males [31].
The majority of service beneficiary were accessed 
malaria care services from private for profit health facili-
ties. In addition, close to one out of ten patients were 
served in Private not for the profit; workplace health 
facilities. This result could be due to the fact that the 
larger groups of PHSP supported facilities are Private for 
Profit facilities [24].
The trend of SPR significantly decreases from 39.4 % in 
the first quarter to 18.4 % in the last quarter (X2 = 4.69, 
P < 0.001). This significant level of result might be attrib-
uted to the reduction in burden of malaria across the 
whole country [32], and might be ascribed to the imple-
mented twelve steps PHSP strategies which ensure the 
quality of services [24]. The average SPR was 25.1 %. This 
finding was a little higher than the national estimated 
slide positivity rate 19.0 % [3]. However, Chala and Per-
tos [5] for the period ranges from 2001 to 2005 reported 
overall SPR was 30.9 % in Finchaa Sugar Plantation and 
Factory site in Ethiopia [5].
In Ethiopia, the two dominant Plasmodium species 
known for causes of malaria infection with annual preva-
lence were 60–70 % P. falciparum and 30–40 % P. vivax 
[2, 4]. Whereas, in this study, almost one half (50.0  %) 
were found to be for P. falciparum and 46.0 % were con-
firmed P. vivax. This research documented a significant 
difference in proportion of Plasmodium species identi-
fied using RDT compared to microscopy. The magni-
tude of P. falciparum among patients diagnosed using 
RDT groups was much higher than patients identified 
using microscopy. Studies reported wide range of differ-
ence in prevalence of Plasmodium species for example 
in North Western Ethiopia 90.0  % P. falciparum were 
documented in 10 years data from Metema Hospital [33], 
while Regassa (2014) found 64 % P. falciparum and 25 % 
P. vivax in SNNP, Arbamich hospital [29].
Figures  4 and 5 depicted the trends of appropriate 
malaria case management to presumed diagnosis, P. fal-
ciparum or mixed, and P. vivax infections, respectively. 
The temporal changes in adherence to recommended 
treatment for presumed diagnosis, P. falciparum or 
mixed infection was improved from 47.8  % in the first 
quarter to 95.7 % in the last quarter. Similarly, adherence 
Table 3 Malaria parasite detection rates using either Microscopy or RDT in PPP facilities Ethiopia, April 2012–September 
2015
Annual summary are presented with italics font
Year Test type Test done Positive Prevalence % Pf Pf % Pv Pv % Mixed Pf/Pv Mixed %
2012 (1) BF 60,727 23,925 39.4 12,825 53.6 9503 39.7 1597 6.7
RDT 1728 773 44.7 415 53.7 291 37.6 67 8.7
BF and RDT 62,455 24,698 39.5 13,240 53.6 9794 39.7 1664 6.7
2013 (2) BF 271,680 77,404 28.5 38,936 50.3 34,362 44.4 4106 5.3
RDT 16,545 6676 40.4 3955 59.2 2558 38.3 163 2.4
BF and RDT 288,225 84,080 29.2 42,891 51.0 36,920 43.9 4269 5.1
2014 (3) BF 307,573 66,407 21.6 34,264 51.6 30,385 45.8 1758 2.6
RDT 21,187 7266 34.3 4185 57.6 2673 36.8 408 5.6
BF and RDT 328,760 73,673 22.4 38,449 52.2 33,058 44.9 2166 2.9
2015 (4) BF 167,295 30,330 18.1 13,768 45.4 15,998 52.7 564 1.9
RDT 5259 1478 28.1 356 24.1 995 67.3 127 8.6
BF and RDT 172,554 31,808 18.4 14,124 44.4 16,993 53.4 691 2.2
Sub total BF 807,275 198,066 24.5 99,793 50.4 90,248 45.6 8025 4.1
Sub total RDT 44,719 16,193 36.2 8911 55.0 6517 40.2 765 4.7
Grand total 851,994 214,259 25.1 108,704 50.7 96,765 45.2 8790 4.1
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to P, vivax infection was improved from 44.1  % in the 
first quarter and 98.1  % in the last quarter. This finding 
was much higher than the baseline survey conducted 
by Argaw (2015) in Ethiopia. However, there are several 
studies documented improvements in adherence to the 
standards [10–14, 34–36].
Limitations
This retrospective descriptive study was made based on 
collected data for Health Information System. This study 
unable to determine and analyse other socio demographic 
characteristics of the clients and other aspects of quality 
service delivery such as provider client interaction.





















AL illegible CQ illegible
Apr–Jun 2012 2 17,984 87.77 7220 40.15 2501 47.88 1425 44.19 
39 20,489 17,984 5223 3225
Jul–Sep 2012 3 44,471 86.67 17,478 39.30 9648 81.76 6569 100.00 
57 51,311 44,471 11,800 6569
Oct–Dec 2012 3 67,511 96.67 24,569 36.39 10,750 68.22 7293 76.36 
57 69,834 67,511 15,758 9551
Jan–Mar 2013 4 69,091 98.61 18,037 26.11 6982 56.08 6483 70.40 
77 70,062 69,091 12,449 9209
Apr–Jun 2013 4 78,297 99.61 20,216 25.82 9825 86.25 6706 71.01 
78 78,606 78,297 11,391 9444
Jul–Sep 2013 5 73,326 98.44 21,258 28.99 10,076 74.82 5727 65.71 
88 74,485 73,326 13,467 8716
Oct–Dec 2013 6 96,721 93.40 27,901 28.85 14,373 85.65 9507 83.81 
100 103,551 96,721 16,781 11,344
Jan–Mar 2014 6 85,498 99.83 17,357 20.30 8897 99.02 8421 98.84 
110 85,645 85,498 8985 8520
Apr–Jun 2014 6 72,869 99.79 12,552 17.23 6108 97.43 6320 98.11 
110 73,019 72,869 6269 6442
Jul–Sep 2014 6 73,673 99.51 15,863 21.53 9082 95.87 6699 99.22 
99 74,035 73,673 9473 6752
Oct–Dec 2014 4 51,875 99.91 12,255 23.62 5402 81.99 5354 93.68 
41 51,924 51,875 6589 5715
Jan–Mar 2015 4 42,766 99.96 6526 15.26 2167 98.10 4264 98.41 
43 42,782 42,766 2209 4333
Apr–Jun 2015 4 37,546 99.86 6103 16.25 2442 95.13 3587 100.00 
43 37,597 37,546 2567 3587
Jul–Sep 2015 4 40,367 100.00 6924 17.15 3417 95.79 3295 98.12 
43 40,368 40,367 3567 3358
Total 851,995 97.51 214,259 25.15 101,670 80.35 81,735 84.47 
873,708 851,995 126,528 96,765
McNemar’s test 66.84 P < 0.001 26.67 P < 0.001 12.89 P < 0.001 11.62 P < 0.001
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Fig. 4 Line chart showing the proportion of confirmed malaria cases treated by region, 2012–2015
Fig. 5 Trends of appropriate treatment using AL (Coartem®) in PPP malaria facilities, Ethiopia, 2012–2015. Line graphs showing adherence of health 
care providers to the nationally recommended treatment for Plasmodium falciparum malaria, mixed malaria and clinical diagnosis malaria
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Conclusions
This study documented the chronological changes of 
adherence of health care providers with the national 
recommended standards to treat malaria. Scaling up of 
PPP for malaria care services is recommended through 
partners and the national malaria prevention control 
programme.
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